These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments. Su JH; Cummings BJ; Cotman CW Brain Res; 1996 Nov; 739(1-2):79-87. PubMed ID: 8955927 [TBL] [Abstract][Full Text] [Related]
3. Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles. Sánchez-Juan P; Valeriano-Lorenzo E; Ruiz-González A; Pastor AB; Rodrigo Lara H; López-González F; Zea-Sevilla MA; Valentí M; Frades B; Ruiz P; Saiz L; Burgueño-García I; Calero M; Del Ser T; Rábano A Brain; 2024 May; 147(5):1667-1679. PubMed ID: 38634687 [TBL] [Abstract][Full Text] [Related]
4. Association of glial fibrillary acid protein, Alzheimer's disease pathology and cognitive decline. Peretti DE; Boccalini C; Ribaldi F; Scheffler M; Marizzoni M; Ashton NJ; Zetterberg H; Blennow K; Frisoni GB; Garibotto V Brain; 2024 Jun; ():. PubMed ID: 38940331 [TBL] [Abstract][Full Text] [Related]
5. Neurogranin in Alzheimer's disease and ageing: A human post-mortem study. Saunders T; Gunn C; Blennow K; Kvartsberg H; Zetterberg H; Shenkin SD; Cox SR; Deary IJ; Smith C; King D; Spires-Jones T Neurobiol Dis; 2023 Feb; 177():105991. PubMed ID: 36623608 [TBL] [Abstract][Full Text] [Related]
6. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort. Chatterjee P; Pedrini S; Doecke JD; Thota R; Villemagne VL; Doré V; Singh AK; Wang P; Rainey-Smith S; Fowler C; Taddei K; Sohrabi HR; Molloy MP; Ames D; Maruff P; Rowe CC; Masters CL; Martins RN; Alzheimers Dement; 2023 Apr; 19(4):1117-1134. PubMed ID: 36574591 [TBL] [Abstract][Full Text] [Related]
16. Distinct brain pathologies associated with Alzheimer's disease biomarker-related phospho-tau 181 and phospho-tau 217 in Hirota Y; Sakakibara Y; Ibaraki K; Takei K; Iijima KM; Sekiya M Brain Commun; 2022; 4(6):fcac286. PubMed ID: 36440096 [TBL] [Abstract][Full Text] [Related]
17. Cross-sectional and longitudinal evaluation of plasma glial fibrillary acidic protein to detect and predict clinical syndromes of Alzheimer's disease. Ally M; Sugarman MA; Zetterberg H; Blennow K; Ashton NJ; Karikari TK; Aparicio HJ; Frank B; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Simkin I; Farrer LA; Jun GR; Turk KW; Budson AE; O'Connor MK; Au R; Goldstein LE; Kowall NW; Killiany R; Stern RA; Stein TD; McKee AC; Qiu WQ; Mez J; Alosco ML Alzheimers Dement (Amst); 2023; 15(4):e12492. PubMed ID: 37885919 [TBL] [Abstract][Full Text] [Related]
18. Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease. Dickson TC; King CE; McCormack GH; Vickers JC Exp Neurol; 1999 Mar; 156(1):100-10. PubMed ID: 10192781 [TBL] [Abstract][Full Text] [Related]
19. Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age. Betthauser TJ; Koscik RL; Jonaitis EM; Allison SL; Cody KA; Erickson CM; Rowley HA; Stone CK; Mueller KD; Clark LR; Carlsson CM; Chin NA; Asthana S; Christian BT; Johnson SC Brain; 2020 Jan; 143(1):320-335. PubMed ID: 31886494 [TBL] [Abstract][Full Text] [Related]
20. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study. de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]